Jacob Myles Keck

PGY-2 trained Infectious Diseases Pharmacist with focused expertise in transplant infectious diseases, opportunistic infections, HIV/AIDS management, and antifungal pharmacotherapy. Adept in interpreting complex clinical data, delivering impactful education, and collaborating with multidisciplinary teams to optimize patient outcomes. Experienced public speaker with a strong background in engaging healthcare professionals, including precepting students and facilitating topic discussions. Passionate about advancing evidence-based care through scientific exchange and eager to apply my clinical and communication skills in a field-based MSL role.

• Keck JM, Dare RK, Jenkins MB, et al. It’s here, it’s there, there’s fungi everywhere: a case series utilizing rezafungin for invasive candidiasis. Infect Dis Ther. 2025; doi.org/10.1007/s40121-025-01120-7.
• Keck JM, Viteri A, Schultz J, et al. New antimicrobial agents are coming, and so is the resistance. Antibiotics. 2024;13:648.
• Toler RL, Hamblin SE, Mangan LE, et al. Assessment of prophylactic antibiotic coverage in culture-positive traumatic open fractures. J Surg Orthop Adv. 2024;33(2):84-87.
• Thompson R, Dare R, Rosenbaum E, et al. Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence ISaba36 in the siderophore receptor pirA. Antimicrob Agents Chemother. 2024;68(7).
• Stover K, Hawkins BK, Keck JM, et al. Antifungal resistance, combinations, and pipeline: oh my! Drugs Context. 2023;12:2023-7.1.
• Keck JM, Cretella DA, Stover KR, et al. Evaluation of an antifungal stewardship initiative targeting micafungin at an academic medical center. 2023; Antibiotics.12 (193):1-11.
• Keck JM, Wingler MJB, Cretella DA, et al. Approach to fever in patients with neutropenia: a review of diagnosis and management. Ther Adv Infect Dis. 2022;9. PMID: 36451936
• Deweese J, Dougherty A, Hawaz M, Trac J, Keck JM. Probing the impact of serine and threonine patches in the c-terminus on the catalytic of human Topoisomerase IIα. The FASEB Journal. 2021;35(S1).
• Keck JM, Perkins N, Adams D, et al. Antimicrobial management of Stenotrophomonas maltophilia pneumonia: does TMP-SMX dose affect treatment failure? Open Forum Infect Dis. 2021;4(8):740.
• Trac J, Keck JM, and Deweese JE. Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone. Journal of Cannabis Research. 2021;3(11):1-7. PMID: 33892826
• Vethody C, Yu R, Keck JM, et al. Safety, efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels. J Allergy Clin Immunol Pract. 2021; 9(2):922-928.
• Deweese JE, Hoang KG, Menzie RA, et al. The variable C‐terminal domain of human type II topoisomerases as a functionally relevant therapeutic target. The FASEB Journal. 2020;33(1):793.4. PMID: 31512855
• Keck JM, Conner JD, Wilson JT, et al. Clarifying the mechanism of copper (II) α-(N)-heterocyclic thiosemicarbazone complexes on DNA topoisomerase IIα and IIB. Chem Res Toxicol. 2019;32(10):2135-2143.

• A stewardship initiative gone wrong? A proposal for the disposal of empirical usage of ertapenem inpatient - Department of Infectious Diseases University of Arkansas Medical Center (ACPE/ACCME/ANCC accredited oral presentation)
• Cefiderocol case series - Shionogi round tables
• Superbugs beware: the arrival of new antibiotics - Arkansas Summit for Antimicrobial Stewardship (ACPE/ACCME/ANCC accredited oral presentation)
• AMS: Is it time for a new perspective? - Department of Infectious Diseases University of Arkansas Medical Center (ACPE/ACCME/ANCC accredited oral presentation)
• Is it eravacycline time? - Department of Infectious Diseases University of Arkansas Medical Center (ACPE/ACCME/ANCC accredited oral presentation)
• Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumanniiis associated with insertion sequence ISaba36 in the siderophore receptor pirA - Arkansas Summit for Antimicrobial Stewardship (poster)
• Disseminated fungal disease: it’s here, it’s there, it invades everywhere - Department of Pharmacy University of Arkansas Medical Center (ACPE accredited oral presentation)
• Resistance mechanisms of bacteria and how we overcome the resistance - Department of Infectious Diseases University of Arkansas Medical Center (ACPE/ACCME/ANCC accredited oral presentation)
• Fosmanogepix and its role in invasive candida infections - Department of Infectious Diseases University of Arkansas Medical Center (ACPE/ACCME/ANCC accredited oral presentation)
• Antimicrobial resistance: the bacteria strike back - Association for Professionals in Infection Control and Epidemiology (APIC) Arkansas Annual Conference (ACPE accredited oral presentation)
• What’s new in the world of Infectious Diseases - Department of Infectious Diseases University of Arkansas Medical Center (ACPE/ACCME/ANCC accredited oral presentation)
• Bone, joint, and diabetic foot infections - Infectious Diseases elective class University of Ole Miss Pharmacy School (oral presentation)
• An overview of skin and soft tissue infections Infectious Diseases elective class University of Ole Miss Pharmacy School (oral presentation)
• Evaluation of a micafungin antifungal stewardship initiative at a large academic medical center - Memphis MidSouth Pharmacy Residency Conference (oral presentation)
• A COVID-19 update - Department of Pharmacy University of Mississippi Medical Center (ACPE accredited oral presentation)
• A synergistic approach with aztreonam - Department of Pharmacy University of Mississippi Medical Center (ACPE accredited oral presentation)
• Treatment of Stenotrophomonas maltophilia pneumonia; a dosing dilemma Pharmacy grand rounds - Baptist Memorial Hospital-Memphis (ACPE accredited oral presentation)
• Treatment of Stenotrophomonas maltophilia pneumonia; a dosing dilemma - Memphis MidSouth Pharmacy Residents Conference (oral presentation)
• Treatment of Stenotrophomonas maltophilia pneumonia; a dosing dilemma 5th Annual Belmont Antimicrobial Stewardship Symposium (poster presentation)
• Usage of antibiograms and the role of antibiotic streamlining - Baptist Memorial Hospital-Memphis Medical Grand Rounds (oral presentation)
• Bacteremia? Viremia? No, no it’s candidemia - Department of Pharmacy Grand Rounds Baptist Memorial Hospital-Memphis (ACPE accredited oral presentation)

• Clarifying the mechanism of copper (II) α-(N)-heterocyclic thiosemicarbazone complexes on DNA topoisomerase IIa and IIB - American Association of Colleges of Pharmacy (AACP) Annual Conference (poster)
• Clarifying the mechanism of copper (II) α-(N)-heterocyclic thiosemicarbazone complexes on DNA topoisomerase IIa and IIB - American Society for Biochemistry and Molecular Biology (ASBMB) Annual Conference (poster)
• Treatment of Stenotrophomonas maltophilia pneumonia; a dosing dilemma - American Society of Health System Pharmacists (ASHP) Midyear meeting (poster)

• Remote Guest editor for the Journal of Antibiotics - Special edition: Revolutionizing infection treatment: cutting-edge approaches in antimicrobial stewardship (2025)
• Lead clinical preceptor for University of Arkansas for Medical Sciences Pharmacy Grand Rounds - Title: To infinity and beyond resistance - (2024)
• Clinical preceptor for the University of Arkansas School of Pharmacy - Infectious Diseases and Antimicrobial Stewardship (2022 - present)
• University of Arkansas for Medical Sciences PGY-1 pharmacy preceptor - Infectious Diseases and Antimicrobial Stewardship (2022 - present)
• University of Arkansas for Medical Sciences PGY-2 critical care pharmacy preceptor - Infectious Diseases and Antimicrobial Stewardship (2022 - present)
• Proxy voter Pharmacy and Therapeutics (P&T) Committee for the Department of Infectious Diseases - University of Arkansas for Medical Sciences (2023 - present)
• Voting member for the Antimicrobial Stewardship Program - University of Arkansas for Medical Sciences (2022 - present)
• Non-voting member for the Infection Prevention Committee - University of Arkansas for Medical Sciences (2023 - present)
• Clinical preceptor for the University of Tennessee School of Pharmacy - Baptist Memorial Hospital-Memphis (2020 - 2021)

• Board Certified Infectious Disease Pharmacist (BCIDP) Credential number: B11102017
• American Academy of HIV Pharmacist (AAHIVP) certification
• Pharmacist in the state of Arkansas License Number: PD16360
• PGY-2 Infectious Diseases pharmacy resident certificate - University of Mississippi Medical Center
• PGY-1 pharmacy resident certificate - Baptist Memorial Hospital-Memphis
• Teaching certificate - University of Tennessee College of Pharmacy
• Registered pharmacist in the state of Tennessee License Number: 44252

• The Society of Healthcare Epidemiology of America (SHEA)
• Society of Infectious Diseases Pharmacists (SIDP)
• Rho Chi Academic Honors Society

• Outstanding Health-System Pharmacy Preceptor - University of Arkansas for Medical Sciences School of Pharmacy (2025)
• Outstanding Health-System Pharmacy Preceptor - University of Arkansas for Medical Sciences School of Pharmacy (2024)
• Pharmaceutical Sciences Research Scholar Designation – awarded to one pharmacy student who demonstrates excellence in the didactic portion of pharmaceutical sciences and has a peer-reviewed publication through Lipscomb University College of Pharmacy (2020)
• Royal Society of Chemistry Certificate – awarded to one pharmacy student at Lipscomb University College of Pharmacy who demonstrates excellence in both pharmaceutical sciences research and medicinal/biochemistry (2020)
• American Association of Colleges of Pharmacy (AACP) Walmart Scholar (2019)